Single-cell multi-omics sequencing reveals the immunological disturbance underlying Kawasaki disease

单细胞多组学测序揭示川崎病潜在的免疫紊乱

阅读:3

Abstract

INTRODUCTION: Kawasaki disease (KD) is an acute autoimmune vasculitis that predominantly affects children under 5 years of age. Although immune dysregulation is considered central to KD pathogenesis, the cellular heterogeneity and regulatory mechanisms underlying this process remain incompletely understood. Single-cell multi-omics technologies provide an opportunity to characterize immune alterations at high resolution. METHODS: Peripheral blood mononuclear cells (PBMCs) were obtained from two children with typical KD and two age-matched healthy controls. Integrated single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) were performed to characterize immune cell composition, transcriptional profiles, and chromatin accessibility. Comparative analyses were conducted to identify altered immune cell subsets and dysregulated signaling pathways in KD. RESULTS: Children with KD exhibited marked immune dysregulation, characterized by altered proportions and functional states of multiple PBMC subsets, including T cells, B cells, and natural killer (NK) cells. Notably, specific NK cell subsets were associated with the pathogenesis of intravenous immunoglobulin (IVIG)-resistant KD. Pathway analyses revealed significant dysregulation of toll-like receptor signaling, B cell and T cell receptor signaling, Th17 and Th1/Th2 differentiation, NK cell-mediated cytotoxicity, and platelet activation pathways. DISCUSSION: By integrating scRNA-seq and scATAC-seq data, this study delineates the heterogeneity of immune cell populations in KD at the single-cell level. The findings highlight coordinated immune and platelet activation pathways that may contribute to KD-associated inflammation and IVIG resistance. These results provide mechanistic insights into KD immunopathogenesis and suggest potential cellular and molecular targets for therapeutic intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。